At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
Neurofeedbackother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Feasibility Study of fMRI-neurofeedback in Parkinson's Disease
In Brief
An observational study evaluating Neurofeedback for Basal-ganglia fMRI Neurofeedback. Completed, enrolled 12 participants across 1 site.
Detailed Summary
To investigate feasibility of basal-ganglia regions as fMRI-neurofeedback targets in Parkinson's patients and evaluate self-regulation success
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBasal-ganglia fMRI Neurofeedback
CountriesNetherlands
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedNov 2022
Enrollment StartAug 2023
Primary CompletionFeb 2024
Study CompletionFeb 2024
TodayJul 2026
First PostedNov 28, 2022
Enrollment StartAug 17, 2023
Primary CompletionFeb 19, 2024
Study CompletionFeb 28, 2024
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.6 years ago
Interventions
Neurofeedbackother
Participants will be shown their brain activity measured in real-time using an MRI scanner. They can then use mental strategies, such as imagination to influence and regulate this activity.